SPECIFIC product book - English

SPECIFIC TM FKW KIDNEY SUPPORT

INDICATIONS

Chronic renal insufficiency

£

£ Hepatic insufficiency (except patients with cholestasis) £ Congestive heart failure, hypertension, oedema £ Urate, oxalate or cystine urolithiasis

7x100 g

SPECIFIC TM FKW KIDNEY SUPPORT

PROPERTIES AND RATIONALE FOR THE COMPOSITION

A restricted content of phosphorus is essential to prevent hyperphosphataemia and to slow down the progression of kidney insufficiency.

Kidney support

EPA and DHA are both omega-3 fatty acids which can help slow down the progression of kidney failure. In cats with cardiac disease, EPA and DHA can support maintenance of lean body mass, appetite and normal blood pressure and platelet aggregation. The content of fish oil, and thereby the level of EPA and DHA, is exceptionally high in SPECIFIC TM FKW Kidney Support. The reduced content of protein in combination with protein of high biological value reduce azotemia in cats with renal failure. In cats with liver failure, it reduces the likelihood of hyperammonemia and possible hepatic encephalopathy. The high biological value of the proteins supplies the cat with sufficient amounts of essential amino acids. In congestive heart failure, sodium excretion is reduced as part of the compensatory response to the reduced cardiac output, and consequently sodium and water retention occurs. The reduced sodium level helps break the vicious circle of water retention. This is essential for both kidney, liver and heart patients. The restricted protein level reduces the urinary concentrations of oxalate, cystine and urate. Together with the alkaline urine pH, this discourages precipitation of urinary calcium oxalate, cystine and urate crystals and supports a healthy urinary tract. Added potassium citrate helps keep calcium oxalate in solution.

Heart & kidney support

Liver & kidney support

Heart & kidney support

SODIUM

Healthy urinary tract support